LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function. - Kumaraswamy A; Duan Z; Flores D; Zhang C; Sehrawat A; Hu YM; Swaim OA; Rodansky E; Storck WK; Kuleape JA; Bedi K; Mannan R; et al. (JCI insight, 2023)